353 related articles for article (PubMed ID: 36753615)
21. Ex vivo cell-based CRISPR/Cas9 genome editing for therapeutic applications.
Li Y; Glass Z; Huang M; Chen ZY; Xu Q
Biomaterials; 2020 Mar; 234():119711. PubMed ID: 31945616
[TBL] [Abstract][Full Text] [Related]
22. Advance genome editing technologies in the treatment of human diseases: CRISPR therapy (Review).
Alagoz M; Kherad N
Int J Mol Med; 2020 Aug; 46(2):521-534. PubMed ID: 32467995
[TBL] [Abstract][Full Text] [Related]
23. Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review.
Ebrahimi V; Hashemi A
Gene; 2020 Aug; 753():144813. PubMed ID: 32470504
[TBL] [Abstract][Full Text] [Related]
24. CRISPR-Cas9 for treating hereditary diseases.
Mani I
Prog Mol Biol Transl Sci; 2021; 181():165-183. PubMed ID: 34127193
[TBL] [Abstract][Full Text] [Related]
25. Translating genomic insights into cardiovascular medicine: Opportunities and challenges of CRISPR-Cas9.
Zhang Y; Karakikes I
Trends Cardiovasc Med; 2021 Aug; 31(6):341-348. PubMed ID: 32603681
[TBL] [Abstract][Full Text] [Related]
26. CRISPR/Cas9 Platforms for Genome Editing in Plants: Developments and Applications.
Ma X; Zhu Q; Chen Y; Liu YG
Mol Plant; 2016 Jul; 9(7):961-74. PubMed ID: 27108381
[TBL] [Abstract][Full Text] [Related]
27. The landscape of CRISPR/Cas9 for inborn errors of metabolism.
Leal AF; Fnu N; Benincore-Flórez E; Herreño-Pachón AM; Echeverri-Peña OY; Alméciga-Díaz CJ; Tomatsu S
Mol Genet Metab; 2023 Jan; 138(1):106968. PubMed ID: 36525790
[TBL] [Abstract][Full Text] [Related]
28. CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential.
Oude Blenke E; Evers MJ; Mastrobattista E; van der Oost J
J Control Release; 2016 Dec; 244(Pt B):139-148. PubMed ID: 27498021
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic gene editing in haematological disorders with CRISPR/Cas9.
Jensen TI; Axelgaard E; Bak RO
Br J Haematol; 2019 Jun; 185(5):821-835. PubMed ID: 30864164
[TBL] [Abstract][Full Text] [Related]
30. Progresses of CRISPR/Cas9 genome editing in forage crops.
Ul Haq SI; Zheng D; Feng N; Jiang X; Qiao F; He JS; Qiu QS
J Plant Physiol; 2022 Dec; 279():153860. PubMed ID: 36371870
[TBL] [Abstract][Full Text] [Related]
31. Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment.
Jiang C; Meng L; Yang B; Luo X
Clin Genet; 2020 Jan; 97(1):73-88. PubMed ID: 31231788
[TBL] [Abstract][Full Text] [Related]
32. Pre-clinical non-viral vectors exploited for
Rouatbi N; McGlynn T; Al-Jamal KT
Biomater Sci; 2022 Jun; 10(13):3410-3432. PubMed ID: 35604372
[TBL] [Abstract][Full Text] [Related]
33. Epigenome editing by CRISPR/Cas9 in clinical settings: possibilities and challenges.
Pei WD; Zhang Y; Yin TL; Yu Y
Brief Funct Genomics; 2020 May; 19(3):215-228. PubMed ID: 31819946
[TBL] [Abstract][Full Text] [Related]
34. Temperature effect on CRISPR-Cas9 mediated genome editing.
Xiang G; Zhang X; An C; Cheng C; Wang H
J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
[TBL] [Abstract][Full Text] [Related]
35. CRISPR/Cas9-Mediated Genome Editing in Cancer Therapy.
Ding S; Liu J; Han X; Tang M
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003514
[TBL] [Abstract][Full Text] [Related]
36. Modulating CRISPR/Cas9 genome-editing activity by small molecules.
Chen S; Chen D; Liu B; Haisma HJ
Drug Discov Today; 2022 Apr; 27(4):951-966. PubMed ID: 34823004
[TBL] [Abstract][Full Text] [Related]
37. CRISPR/Cas9 Genome Editing Tool: A Promising Tool for Therapeutic Applications on Respiratory Diseases.
Shaikh SB; Bhandary YP
Curr Gene Ther; 2020; 20(5):333-346. PubMed ID: 33045965
[TBL] [Abstract][Full Text] [Related]
38. Can genetic engineering-based methods for gene function identification be eclipsed by genome editing in plants? A comparison of methodologies.
Amritha PP; Shah JM
Mol Genet Genomics; 2021 May; 296(3):485-500. PubMed ID: 33751237
[TBL] [Abstract][Full Text] [Related]
39. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
Liu W; Yang C; Liu Y; Jiang G
Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
[TBL] [Abstract][Full Text] [Related]
40. The application of genome editing in studying hearing loss.
Zou B; Mittal R; Grati M; Lu Z; Shu Y; Tao Y; Feng Y; Xie D; Kong W; Yang S; Chen ZY; Liu X
Hear Res; 2015 Sep; 327():102-8. PubMed ID: 25987504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
